Patents by Inventor David Cantin

David Cantin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240331128
    Abstract: A control circuit can access inspection results from an inspection of a first component and then input those inspection results to a first machine learning model. The inspection results include potential wear indications. By one approach, that first machine learning model is trained using a training corpus that includes inspection results for previously inspected components that are at least similar to the first component. The first machine learning model can output assessment information that, by one approach, identifies some of the potential wear indications as being relevant. By one approach, the aforementioned assessment information may be input a second machine learning model that is trained using a training corpus that includes historical results from previous inspections of the same first component and wherein the second machine learning model outputs prediction information regarding whether a repeated physical processing of the first component will yield a particular result.
    Type: Application
    Filed: March 31, 2023
    Publication date: October 3, 2024
    Inventors: John Karigiannis, Shaopeng Liu, James Vradenburg Miller, Peihong Zhu, David Cantin, Jonathan R. Hootman
  • Publication number: 20230406851
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 26, 2023
    Publication date: December 21, 2023
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Patent number: 11504853
    Abstract: A system includes a first sensor having a fixed location relative to a workspace, a second sensor, at least one robotic manipulator coupled to a manipulation tool, and a control system in communication with the at least one robotic manipulator. The control system is configured to determine a location of a workpiece in the workspace based on first sensor data from the first sensor and a three-dimensional (3D) model corresponding to the workpiece. The control system is configured to map a set of 2D coordinates from a second 2D image from the second sensor to a set of 3D coordinates based on the location, and to generate one or more control signals for the at least one robotic manipulator based on the set of 3D coordinates.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: November 22, 2022
    Assignee: General Electric Company
    Inventors: Stephane Harel, Steeves Bouchard, John Karigiannis, Antoine Lizotte, MarcAndre Montplaisir, Nicolas Saudrais, David Cantin
  • Publication number: 20220062290
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: November 10, 2021
    Publication date: March 3, 2022
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Publication number: 20210228588
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: April 8, 2021
    Publication date: July 29, 2021
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Publication number: 20200390779
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: August 27, 2020
    Publication date: December 17, 2020
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Patent number: 10726543
    Abstract: An inspection system includes one or more processors that obtain a first image of a work piece that has a fluorescent dye thereon in an ultraviolet (UV) light setting and a second image of the work piece in a visible light setting. The first and second images are generated by one or more imaging devices in the same position relative to the work piece. The one or more processors identify a candidate region of the first image based on a light characteristic of one or more pixels, and determine a corresponding candidate region of the second image that is at an analogous location as the candidate region of the first image. The one or more processors analyze both candidate regions to detect a potential defect on a surface of the work piece and a location of the potential defect relative to the surface of the work piece.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: July 28, 2020
    Assignee: General Electric Company
    Inventors: Xiao Bian, Steeves Bouchard, David Cantin, Stephane Harel, John Karigiannis, David Scott Diwinsky, Bernard Bewlay
  • Publication number: 20200167905
    Abstract: An inspection system includes one or more processors that obtain a first image of a work piece that has a fluorescent dye thereon in an ultraviolet (UV) light setting and a second image of the work piece in a visible light setting. The first and second images are generated by one or more imaging devices in the same position relative to the work piece. The one or more processors identify a candidate region of the first image based on a light characteristic of one or more pixels, and determine a corresponding candidate region of the second image that is at an analogous location as the candidate region of the first image. The one or more processors analyze both candidate regions to detect a potential defect on a surface of the work piece and a location of the potential defect relative to the surface of the work piece.
    Type: Application
    Filed: November 27, 2018
    Publication date: May 28, 2020
    Inventors: Xiao Bian, Steeves Bouchard, David Cantin, Stephane Harel, John Karigiannis, David Scott Diwinsky, Bernard Bewlay
  • Publication number: 20200138826
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 7, 2020
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Publication number: 20190231789
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: April 4, 2019
    Publication date: August 1, 2019
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Publication number: 20190143523
    Abstract: A system includes a first sensor having a fixed location relative to a workspace, a second sensor, at least one robotic manipulator coupled to a manipulation tool, and a control system in communication with the at least one robotic manipulator. The control system is configured to determine a location of a workpiece in the workspace based on first sensor data from the first sensor and a three-dimensional (3D) model corresponding to the workpiece. The control system is configured to map a set of 2D coordinates from a second 2D image from the second sensor to a set of 3D coordinates based on the location, and to generate one or more control signals for the at least one robotic manipulator based on the set of 3D coordinates.
    Type: Application
    Filed: November 16, 2017
    Publication date: May 16, 2019
    Inventors: Stephane Harel, Steeves Bouchard, John Karigiannis, Antoine Lizotte, MarcAndre Montplaisir, Nicolas Saudrais, David Cantin
  • Publication number: 20190030040
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 31, 2019
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Patent number: 10060857
    Abstract: A system includes one or more processors configured to create a projection matrix based on a three-dimensional (3D) model of a part and sensor data associated with a workpiece in a workspace of a robotic manipulator. The projection matrix provides a mapping between sensor coordinates associated with the sensor data and 3D coordinates associated with the 3D model. The one or more processors are configured to identify a set of sensor coordinates from the sensor data corresponding to a feature indication associated with the workpiece, and to determine from the set of sensor coordinates a set of 3D coordinates using the projection matrix.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: August 28, 2018
    Assignee: General Electric Company
    Inventors: Steeves Bouchard, Stephane Harel, John Karigiannis, Nicolas Saudrais, David Cantin, Ser Nam Lim, Maxime Beaudoin Pouliot, Jean-Philippe Choiniere
  • Patent number: 9937185
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: April 10, 2018
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Publication number: 20180015099
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: September 26, 2017
    Publication date: January 18, 2018
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Patent number: 9814725
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processesor making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: November 14, 2017
    Assignee: NEOMED INSTITUTE
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Publication number: 20170143730
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: February 2, 2017
    Publication date: May 25, 2017
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Patent number: 9598409
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: March 21, 2017
    Assignee: Neomed Institute
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Publication number: 20150361078
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 17, 2015
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Publication number: 20150057316
    Abstract: The present description relates to compounds of Formula I (A+ X?), a diastereoisomer, an enantiomer, or a mixture thereof, pharmaceutical composition comprising same and uses thereof for gastrointestinal endoscopic and medical imaging applications, and for the treatment of visceral pain: Where R1 and R2 are as defined herein
    Type: Application
    Filed: March 11, 2013
    Publication date: February 26, 2015
    Inventors: Jean-Francois Meunier, Cheuk Kun Lau, Daniel Guay, Gregory Bydlinski, Nadejda Spassova, Louis-David Cantin, Maxime Ranger